These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36375640)

  • 1. Clinical utility of C-reactive protein-based triage for presumptive pulmonary tuberculosis in South African adults.
    Calderwood CJ; Reeve BW; Mann T; Palmer Z; Nyawo G; Mishra H; Ndlangalavu G; Abubakar I; Noursadeghi M; Theron G; Gupta RK
    J Infect; 2023 Jan; 86(1):24-32. PubMed ID: 36375640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood RNA signatures outperform CRP triage of tuberculosis lymphadenitis and pericarditis.
    Mann T; Minnies S; Gupta RK; Reeve BW; Nyawo G; Palmer Z; Naidoo C; Doubell A; Pecararo A; John TJ; Schubert P; Calderwood CJ; Chandran A; Theron G; Noursadeghi M
    medRxiv; 2024 Jul; ():. PubMed ID: 38946942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood transcriptional biomarkers for active pulmonary tuberculosis in a high-burden setting: a prospective, observational, diagnostic accuracy study.
    Turner CT; Gupta RK; Tsaliki E; Roe JK; Mondal P; Nyawo GR; Palmer Z; Miller RF; Reeve BW; Theron G; Noursadeghi M
    Lancet Respir Med; 2020 Apr; 8(4):407-419. PubMed ID: 32178775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Point-of-care C-reactive protein and Xpert MTB/RIF Ultra for tuberculosis screening and diagnosis in unselected antiretroviral therapy initiators: a prospective diagnostic accuracy study.
    Reeve BW; Ndlangalavu G; Mishra H; Palmer Z; Tshivhula H; Rockman L; Naidoo S; Mbu DL; Naidoo CC; Derendinger B; Walzl G; Malherbe ST; van Helden PD; Semitala FC; Yoon C; Gupta RK; Noursadeghi M; Warren RM; Theron G
    medRxiv; 2023 Jun; ():. PubMed ID: 37333303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point-of-care C-reactive protein and Xpert MTB/RIF Ultra for tuberculosis screening and diagnosis in unselected antiretroviral therapy initiators: a prospective, cross-sectional, diagnostic accuracy study.
    Reeve BWP; Ndlangalavu G; Mishra H; Palmer Z; Tshivhula H; Rockman L; Naidoo S; Mbu DL; Naidoo CC; Derendinger B; Walzl G; Malherbe ST; van Helden PD; Semitala FC; Yoon C; Gupta RK; Noursadeghi M; Warren RM; Theron G
    Lancet Glob Health; 2024 May; 12(5):e793-e803. PubMed ID: 38583458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood RNA biomarkers for tuberculosis screening in people living with HIV before antiretroviral therapy initiation: a diagnostic accuracy study.
    Mann T; Gupta RK; Reeve BWP; Ndlangalavu G; Chandran A; Krishna AP; Calderwood CJ; Tshivhula H; Palmer Z; Naidoo S; Mbu DL; Theron G; Noursadeghi M
    Lancet Glob Health; 2024 May; 12(5):e783-e792. PubMed ID: 38583459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of C-Reactive Protein for Tuberculosis Detection in General-Population Screening and Ambulatory-Care Triage in Uganda.
    Cox SR; Erisa KC; Kitonsa PJ; Nalutaaya A; Nantale M; Kayondo F; Mukiibi J; Mukiibi M; Nakasolya O; Dowdy DW; Katamba A; Kendall EA
    Ann Am Thorac Soc; 2024 Jun; 21(6):875-883. PubMed ID: 38259069
    [No Abstract]   [Full Text] [Related]  

  • 8. Blood RNA biomarkers for tuberculosis screening in people living with HIV prior to anti-retroviral therapy initiation: A diagnostic accuracy study.
    Mann T; Gupta RK; Reeve BW; Ndlangalavu G; Chandran A; Krishna AP; Calderwood CJ; Tshivhula H; Palmer Z; Naidoo S; Mbu DL; Theron G; Noursadeghi M
    medRxiv; 2023 Jun; ():. PubMed ID: 37397982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Xpert MTB Host Response assay for the triage of patients with presumed pulmonary tuberculosis: a prospective diagnostic accuracy study in Viet Nam, India, the Philippines, Uganda, and South Africa.
    Gupta-Wright A; Ha H; Abdulgadar S; Crowder R; Emmanuel J; Mukwatamundu J; Marcelo D; Phillips PPJ; Christopher DJ; Nhung NV; Theron G; Yu C; Nahid P; Cattamanchi A; Worodria W; Denkinger CM;
    Lancet Glob Health; 2024 Feb; 12(2):e226-e234. PubMed ID: 38245113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xpert MTB/RIF and Xpert Ultra assays for screening for pulmonary tuberculosis and rifampicin resistance in adults, irrespective of signs or symptoms.
    Shapiro AE; Ross JM; Yao M; Schiller I; Kohli M; Dendukuri N; Steingart KR; Horne DJ
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013694. PubMed ID: 33755189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-reactive protein as a screening test for HIV-associated pulmonary tuberculosis prior to antiretroviral therapy in South Africa.
    Shapiro AE; Hong T; Govere S; Thulare H; Moosa MY; Dorasamy A; Wallis CL; Celum CL; Grosset J; Drain PK
    AIDS; 2018 Aug; 32(13):1811-1820. PubMed ID: 29847333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the diagnostic performance of laboratory-based c-reactive protein as a triage test for active pulmonary tuberculosis.
    Samuels THA; Wyss R; Ongarello S; Moore DAJ; Schumacher SG; Denkinger CM
    PLoS One; 2021; 16(7):e0254002. PubMed ID: 34252128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Accuracy Study of a Novel Blood-Based Assay for Identification of Tuberculosis in People Living with HIV.
    Södersten E; Ongarello S; Mantsoki A; Wyss R; Persing DH; Banderby S; Strömqvist Meuzelaar L; Prieto J; Gnanashanmugam D; Khatri P; Schumacher SG; Denkinger CM
    J Clin Microbiol; 2021 Feb; 59(3):. PubMed ID: 33298607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid diagnosis of pulmonary tuberculosis in African children in a primary care setting by use of Xpert MTB/RIF on respiratory specimens: a prospective study.
    Zar HJ; Workman L; Isaacs W; Dheda K; Zemanay W; Nicol MP
    Lancet Glob Health; 2013 Aug; 1(2):e97-e104. PubMed ID: 25104164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical score for identifying active tuberculosis while awaiting microbiological results: Development and validation of a multivariable prediction model in sub-Saharan Africa.
    Baik Y; Rickman HM; Hanrahan CF; Mmolawa L; Kitonsa PJ; Sewelana T; Nalutaaya A; Kendall EA; Lebina L; Martinson N; Katamba A; Dowdy DW
    PLoS Med; 2020 Nov; 17(11):e1003420. PubMed ID: 33170838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.
    Scott LE; McCarthy K; Gous N; Nduna M; Van Rie A; Sanne I; Venter WF; Duse A; Stevens W
    PLoS Med; 2011 Jul; 8(7):e1001061. PubMed ID: 21814495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing.
    Peter J; Theron G; Chanda D; Clowes P; Rachow A; Lesosky M; Hoelscher M; Mwaba P; Pym A; Dheda K;
    BMC Infect Dis; 2015 Jul; 15():262. PubMed ID: 26156025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chest X-ray interpretation does not complement Xpert MTB/RIF in diagnosis of smear-negative pulmonary tuberculosis among TB-HIV co-infected adults in a resource-limited setting.
    Nakiyingi L; Bwanika JM; Ssengooba W; Mubiru F; Nakanjako D; Joloba ML; Mayanja-Kizza H; Manabe YC
    BMC Infect Dis; 2021 Jan; 21(1):63. PubMed ID: 33435896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burden of tuberculosis in intensive care units in Cape Town, South Africa, and assessment of the accuracy and effect on patient outcomes of the Xpert MTB/RIF test on tracheal aspirate samples for diagnosis of pulmonary tuberculosis: a prospective burden of disease study with a nested randomised controlled trial.
    Calligaro GL; Theron G; Khalfey H; Peter J; Meldau R; Matinyenya B; Davids M; Smith L; Pooran A; Lesosky M; Esmail A; Miller MG; Piercy J; Michell L; Dawson R; Raine RI; Joubert I; Dheda K
    Lancet Respir Med; 2015 Aug; 3(8):621-30. PubMed ID: 26208996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin.
    Pillay S; Steingart KR; Davies GR; Chaplin M; De Vos M; Schumacher SG; Warren R; Theron G
    Cochrane Database Syst Rev; 2022 May; 5(5):CD014841. PubMed ID: 35583175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.